<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02258230</url>
  </required_header>
  <id_info>
    <org_study_id>4859</org_study_id>
    <nct_id>NCT02258230</nct_id>
  </id_info>
  <brief_title>Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair</brief_title>
  <official_title>Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Olympus Corporation of the Americas</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Urogynecology Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Olympus Corporation of the Americas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare operative times and complications of sacral colpopexy and paravaginal repair between
      two-dimensional and three-dimensional laparoscopic systems.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to compare operative times of laparoscopic sacral colpopexy
      (LSC) for the treatment of symptomatic vaginal vault prolapse as well as paravaginal repair
      (PVR) for symptomatic cystocele between two-dimensional and three-dimensional laparoscopic
      systems. Additionally this study will evaluate postoperative complications from surgeries
      performed using two-dimensional versus three-dimensional laparoscopic systems.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operative Times</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Operative times of laparoscopic sacral colpopexy and paravaginal repair procedures from the first part of dissection until closure of the peritoneum.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Intraoperative up to 6 weeks post procedure</time_frame>
    <description>Intraoperative complications will be recorded. Post operative complications will be reported for the first 6 weeks after the procedure.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">194</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Cystocele</condition>
  <arm_group>
    <arm_group_label>2D mode LSC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2D mode of the 3D Laparoscopic Video System for the Laprascopic Sacral Colpopexy (LSC) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D mode LSC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3D mode of the 3D Laparoscopic Video System for the Laprascopic Sacral Colpopexy (LSC) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D mode PVR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2D mode of the 3D Laparoscopic Video System for the Paravaginal Repair (PVR) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D mode PVR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3D mode of the 3D Laparoscopic Video System for the Paravaginal Repair (PVR) arm. Use of the 3D laparoscopic system can be switched to either 2D or 3D.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3D mode of the 3D Laparoscopic Video System</intervention_name>
    <description>Olympus 3DV-190 3D Visualization Unit. LTF-190-10-3D: ENDOEYE FLEX 3D Videoscope.</description>
    <arm_group_label>3D mode LSC</arm_group_label>
    <arm_group_label>3D mode PVR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2D mode of the 3D Laparoscopic Video System</intervention_name>
    <description>Olympus 3DV-190 3D Visualization Unit. LTF-190-10-3D: ENDOEYE FLEX 3D Videoscope.</description>
    <arm_group_label>2D mode LSC</arm_group_label>
    <arm_group_label>2D mode PVR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic vaginal vault prolapse (stage 2 or greater point C-1 pelvic organ prolapse
             quantification [POP-Q] or grade 2 or greater Baden-Walker half way system) undergoing
             laparoscopic sacral colpopexy

        And/Or

          -  Symptomatic cystocele (stage 2 or greater, point Aa or Ba &gt; -1 POP-Q or grade 2 or
             greater Baden-Walker half way system) undergoing laparoscopic paravaginal repair

        Exclusion Criteria:

          -  Age less than 18 years

          -  Inability to comprehend questionnaires

          -  Inability to give informed consent or to return for review

          -  Vaginal vault prolapse &lt; stage 2

          -  Unable to undergo general anesthesia

          -  More than 5 previous laparotomies

          -  Prior sacral colpopexy or vaginal mesh prolapse procedure

          -  Prior surgery involving the retropubic space

          -  Vaginal length less than 6 cm
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert D Moore, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Urogynecology Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beverly Hills Sunset Surgery Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northside Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.miklosandmoore.com/</url>
    <description>International Urogynecology Associates' website</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2014</study_first_submitted>
  <study_first_submitted_qc>October 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2014</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
    <mesh_term>Cystocele</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

